Detection of metastases using circulating tumour DNA in uveal melanoma

BACKGROUND: Approximately 50% of uveal melanoma (UM) patients will develop metastatic disease depending on the genetic features of the primary tumour. Patients need 3–12 monthly scans, depending on their prognosis, which is costly and often non-specific. Circulating tumour DNA (ctDNA) quantification...

Descripción completa

Detalles Bibliográficos
Autores principales: Beasley, Aaron B., de Bruyn, Daniël P., Calapre, Leslie, Al-Ogaili, Zeyad, Isaacs, Timothy W., Bentel, Jacqueline, Reid, Anna L., Dwarkasing, Roy S., Pereira, Michelle R., Khattak, Muhammad A., Meniawy, Tarek M., Millward, Michael, Brosens, Erwin, de Klein, Annelies, Chen, Fred K., Kiliҫ, Emine, Gray, Elin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602949/
https://www.ncbi.nlm.nih.gov/pubmed/37608028
http://dx.doi.org/10.1007/s00432-023-05271-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602949/
https://www.ncbi.nlm.nih.gov/pubmed/37608028
http://dx.doi.org/10.1007/s00432-023-05271-3

Ejemplares similares